Lorrach, Germany

Ralf Koberstein

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 5.4

ph-index = 9

Forward Citations = 173(Granted Patents)


Location History:

  • Lörrach, DE (2004 - 2012)
  • Lorrach, DE (2010 - 2012)
  • Lorrach, GE (2012)

Company Filing History:


Years Active: 2004-2012

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Ralf Koberstein: Innovator in Medicinal Chemistry

Introduction

Ralf Koberstein is a prominent inventor based in Lorrach, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that act as orexin receptor antagonists. With a total of 18 patents to his name, Koberstein's work has the potential to impact therapeutic approaches for various medical conditions.

Latest Patents

Among his latest patents, Koberstein has developed 2-aza-bicyclo[3.3.0]octane derivatives. This invention relates to compounds of Formula (I), which are described in detail in the patent documentation. These compounds, along with their pharmaceutically acceptable salts, are proposed for use as medicaments, specifically targeting orexin receptors. Another notable patent involves pyrrolidines and piperidines, which also serve as orexin receptor antagonists. The compounds in this patent are similarly defined by a specific formula and are intended for medicinal applications.

Career Highlights

Koberstein has worked with Actelion Pharmaceuticals Ltd, where he has been involved in groundbreaking research and development. His expertise in medicinal chemistry has allowed him to contribute to innovative solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Koberstein has collaborated with notable professionals in the field, including Hamed Aissaoui and Thierry Sifferlen. These collaborations have further enriched his research and development efforts.

Conclusion

Ralf Koberstein's contributions to medicinal chemistry, particularly in the area of orexin receptor antagonists, highlight his innovative spirit and dedication to advancing medical science. His extensive patent portfolio reflects his commitment to developing effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…